General Information of Drug (ID: DM8TA0M)

Drug Name
N,N'-Di-acenaphthen-5-yl-guanidine
Synonyms
CHEMBL307395; 157970-69-9; Cns 1145; 1,3-di(1,2-dihydroacenaphthylen-5-yl)guanidine; AC1L4RHN; AC1Q4SU4; Cns-1145; SCHEMBL6155294; CTK4C9538; N,N'-Bis(5-acenaphthyl)guanidine; BDBM50285278; N,N''-Di-acenaphthen-5-yl-guanidine; AKOS030602590; 1,2-bis(1,2-dihydroacenaphthylen-5-yl)guanidine
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 363.5
Logarithm of the Partition Coefficient (xlogp) 5.5
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 1
Chemical Identifiers
Formula
C25H21N3
IUPAC Name
1,2-bis(1,2-dihydroacenaphthylen-5-yl)guanidine
Canonical SMILES
C1CC2=CC=C(C3=CC=CC1=C23)NC(=NC4=CC=C5CCC6=C5C4=CC=C6)N
InChI
InChI=1S/C25H21N3/c26-25(27-21-13-11-17-9-7-15-3-1-5-19(21)23(15)17)28-22-14-12-18-10-8-16-4-2-6-20(22)24(16)18/h1-6,11-14H,7-10H2,(H3,26,27,28)
InChIKey
DPWVUEQXMOBVOQ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
190902
CAS Number
157970-69-9
TTD ID
D07FEO

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Voltage-gated calcium channel alpha Cav1.3 (CACNA1D) TT7RGTM CAC1D_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Synthesis and characterization of N-(acenaphth-5-yl)-N'-(4-methoxynaphth-1-yl)guanidine as a glutamate release inhibitor and potential anti-ischemic agent, Bioorg. Med. Chem. Lett. 5(19):2259-2262 (1995).